Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AVN-944 (VX-944)(VX-944) is a selective, noncompetitive inhibitor of human IMPDH with Ki of 6-10 nM for IMPDH1/IMPDH2.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 139.00 | |
25 mg | In stock | $ 297.00 | |
50 mg | In stock | $ 478.00 | |
100 mg | In stock | $ 688.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 98.00 |
Description | AVN-944 (VX-944)(VX-944) is a selective, noncompetitive inhibitor of human IMPDH with Ki of 6-10 nM for IMPDH1/IMPDH2. |
Targets&IC50 | IMPDH:6-10 nM(Ki) |
Synonyms | VX-944 |
Molecular Weight | 477.51 |
Formula | C25H27N5O5 |
CAS No. | 297730-17-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (115.18 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AVN-944 297730-17-7 Metabolism Dehydrogenase VX944 AVN944 multiple myeloma RPMI8226 Caspase VX 944 Apoptosis BMSCs IMPDH Arenavirus Bcl-2 Family U266 cells inhibit DNA/RNA Synthesis acute myeloid leukemia AML MM.1S oncolytic activity VX-944 Inhibitor AIF Endo G AVN 944 caspase-independent inhibitor